U.S. Healthtech Stock News

Apple’s decision to lift MacBook and iPad prices as memory and storage costs climb is rippling through the entire consumer electronics sector, not just Apple stock. Higher input costs, rising average selling prices and potential shifts in demand are now key pressure points for manufacturers and suppliers alike. For investors, that raises the question of which consumer electronics manufacturers could be positioned to benefit from this AI driven memory squeeze, and which might feel more of a...

Blackstone (NYSE:BX) plans to invest $30b in artificial intelligence focused data centers in Japan. The company expects to deploy this capital over the next three to five years. The commitment targets Japan's growing data center infrastructure to support AI workloads. For investors tracking Blackstone, this move comes as the stock trades around $112.99, with performance under pressure in the near term. Shares are down 9.6% over the past week, 4.7% over the past month, and 28.8% year to...

Investors may be wondering whether Axogen at US$42.52 still makes sense after such a strong run, or if the current price is getting ahead of itself. The stock has pulled back about 4.6% over the past week, after rising 4.0% over 30 days, 37.2% year to date, 314.8% over 1 year and 373.5% over 3 years, with a 96.8% return across 5 years. Recent coverage has focused on Axogen's share price performance and how the stock's sharp moves compare with broader medical equipment peers. This has put...

Recent Phase II results for Dabogratinib, Tyra Biosciences (TYRA) experimental therapy for non-muscle invasive bladder cancer, have drawn fresh attention to the company, its late stage pipeline, and how the stock reflects that potential. See our latest analysis for Tyra Biosciences. Tyra Biosciences share price has been volatile around the latest Dabogratinib update, with a 1-day share price return of 1.03% and 7-day share price return of 4.47%, set against a 30-day share price return that is...

Merck KGaA, traded in the U.S. via NYSE:MRK, agreed to acquire Bio-Techne Corporation in an US$11.3b transaction. The deal is structured to expand Merck KGaA’s reach in life sciences tools, diagnostics, and biomanufacturing support. The acquisition is intended to strengthen Merck KGaA’s position in the U.S. life sciences market and broaden its capabilities across the drug development value chain. For investors following Merck, this deal increases attention on the company’s life sciences...

Daktronics, Inc. recently reported fourth-quarter 2026 sales of US$208.61 million and net income of US$8.42 million, alongside full-year sales of US$838.71 million and net income of US$45.38 million, marking a shift from losses a year earlier. At the same time, Daktronics increased its equity buyback authorization to US$40 million, underlining management’s confidence in the company’s financial position and cash-generation profile. We’ll now look at how Daktronics’ move from loss to profit...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Himax...

MGM Resorts International and BetMGM recently renewed their multi‑year partnerships with Major League Baseball, keeping MGM as MLB’s exclusive Integrated Resort & Casino Partner and extending BetMGM’s marketing presence across MLB media, events, and co‑branded gaming products in the U.S. and Canada. This renewal strengthens MGM’s access to baseball fans through awards events in Las Vegas, team partnerships, and MLB‑themed betting and casino experiences, potentially deepening the link between...

STAAR Surgical recently filed a US$110.604 million shelf registration for 3,900,000 common shares and, following shareholder approval, expanded its Omnibus Equity Incentive Plan by the same number of shares. This combination of new capital-raising capacity and enlarged equity compensation pool, reflected in fresh grants to multiple directors, points to an emphasis on financial flexibility and alignment of leadership incentives with long-term company performance. We’ll now examine how STAAR...

Williams Sonoma and Williams Sonoma Home, portfolio brands of Williams-Sonoma, Inc., recently launched a past collaboration with fashion and lifestyle brand Hill House Home, introducing co-branded dinnerware, kitchen textiles, bedding, furniture, and decorative accents featuring romantic florals, soft palettes, and heirloom-inspired details. The partnership highlights Williams-Sonoma’s emphasis on differentiated, design-led assortments that can deepen appeal among younger, style-conscious...

Recent Performance Snapshot for Adecoagro Stock Adecoagro (AGRO) has drawn attention after a period of mixed share performance, with the stock down 2.8% over the past day and 5.5% over the past week, yet still positive year to date. Over the past month the stock has fallen 28.9%, and over the past 3 months it has declined 34.2%. The 1 year total return of 3.9% contrasts with a 3 year total return of 10.1% and a 5 year total return of 5.2%. See our latest analysis for Adecoagro. The recent...

Readers hoping to buy AXIS Capital Holdings Limited ( NYSE:AXS ) for its dividend will need to make their move shortly...

Despite posting some strong earnings, the market for Golar LNG Limited's ( NASDAQ:GLNG ) stock hasn't moved much. We...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see ReposiTrak...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

TopBuild (NYSE:BLD) is moving ahead with its proposed merger with QXO as stockholders pursue a legal challenge focused on the company’s proxy disclosures. The merger process is taking place alongside major recent amendments to TopBuild’s senior debt terms that are tied to financing the acquisition. These developments affect TopBuild’s governance and capital structure and add new information to the merger story beyond earlier valuation focused discussion. TopBuild, a large installer and...

If you are wondering whether Microchip Technology at around US$92 a share is still attractively priced or starting to look expensive, the key is to separate short term noise from underlying value. The stock has pulled back recently, with the price down 7.3% over the past week and 5.7% over the past month, although it still shows returns of 42.2% year to date and 34.2% over the last year. Recent news around Microchip Technology has focused on its position within the broader semiconductor...

If you are wondering whether Anterix stock is still reasonably priced after its strong run, the next sections will walk through what the current valuation might be telling you. The stock last closed at US$79.09, with returns of 6.1% over the past week, 24.1% over the past month, 255.8% year to date, and 200.3% over the past year. This performance has put Anterix firmly on many investors' radar as they reassess potential reward and risk. Recent news around Anterix has focused on its position...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Canterbury...

Earlier in June 2026, CNH Industrial inaugurated a EUR 21 million virtual simulation ecosystem and automated AutoStore logistics warehouse at its San Matteo R&D hub in Modena, Italy, while its subsidiary CNH Industrial Capital LLC priced US$600 million of 4.950% notes due 2031 for working capital, general purposes, and potential debt repayment. The virtual-first R&D platform and high-speed robotic warehouse are intended to accelerate product development, cut testing emissions, and sharply...

The market rallied behind Deswell Industries, Inc.'s ( NASDAQ:DSWL ) stock, leading do a rise in the share price after...

Over the last 7 days, the United States market has dropped 2.5%, yet it remains up by 20% over the past year, with earnings forecasted to grow annually by 19%. In this dynamic environment, identifying high growth tech stocks involves evaluating their potential to capitalize on technological advancements and market trends while navigating recent fluctuations.

Over the last 7 days, the United States market has dropped 2.5%, yet it has risen by 20% over the past year with earnings forecasted to grow by 19% annually. In this context of fluctuating short-term performance and promising long-term growth potential, identifying stocks that are trading significantly below their intrinsic value estimates can offer attractive opportunities for investors seeking value in a robust market environment.

In the United States market, recent fluctuations have seen a 2.5% drop over the last week, yet it still boasts a 20% increase over the past year with anticipated earnings growth of 19% annually in the coming years. In such an environment, stocks with strong insider ownership can be particularly appealing as they often signal confidence from those closest to the company's operations and long-term potential.